These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 14294007)

  • 41. IMMUNIZATION AGAINST DIPHTHERIA AND TETANUS.
    SMITH JW
    Br J Clin Pract; 1963 Nov; 17():683-7. PubMed ID: 14083939
    [No Abstract]   [Full Text] [Related]  

  • 42. Response to diphtheria booster vaccination in healthy adults: vaccine trial.
    Vellinga A; Van Damme P; Joossens E; Goossens H
    BMJ; 2000 Jan; 320(7229):217. PubMed ID: 10642229
    [No Abstract]   [Full Text] [Related]  

  • 43. A DIPHTHERIA-TETANUS-POLIOMYELITIS VACCINE.
    DANE DS; DICK GW; HAIRE M; BRIGGS EM; CONNOR TJ
    Lancet; 1965 Apr; 1(7391):877-9. PubMed ID: 14272681
    [No Abstract]   [Full Text] [Related]  

  • 44. Immune status and booster effects of low doses of diphtheria toxoid in Swedish medical personnel.
    Björkholm B; Wahl M; Granström M; Hagberg L
    Scand J Infect Dis; 1989; 21(4):429-34. PubMed ID: 2587945
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Diphtheria vaccine: WHO position paper – August 2017.
    Wkly Epidemiol Rec; 2017 Aug; 92(31):417-35. PubMed ID: 28776357
    [No Abstract]   [Full Text] [Related]  

  • 46. [Neural complications after diphtheria vaccination and inoculations with diphtheria toxoid-mixed vaccines. Observations on their etiopathogenesis].
    Ehrengut W
    Dtsch Med Wochenschr; 1986 Jun; 111(24):939-42. PubMed ID: 3709371
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Antitoxin titers following immunization with protamineprecipitated diptheria toxoid.
    ROSS V; CLAPP FL; SCHIMPF BW
    Am J Public Health Nations Health; 1946 Jun; 36():645-9. PubMed ID: 20984362
    [No Abstract]   [Full Text] [Related]  

  • 48. Immunochemical studies of antitoxin produced in normal and allergic individuals hyperimmunized with diphtheria toxoid. I. Relationship of skin sensitivity to purified diphtheria toxoid to the presence of circulating, non-precipitating antitoxin.
    KUHNS WJ; PAPPENHEIMER AM
    J Exp Med; 1952 Apr; 95(4):363-74. PubMed ID: 14938506
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Fall-off in immunity following diphtheria revaccination--an 8 year follow-up study.
    Simonsen O; Kristiansen M; Aggerbeck H; Hau C; Heron I
    APMIS; 1996 Dec; 104(12):921-5. PubMed ID: 9048872
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Combined diphtheria-tetanus immunization of adults.
    Trinca JC
    Med J Aust; 1975 Oct; 2(14):543-6. PubMed ID: 1196209
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Immunity and immunization of children against diphtheria in Sweden.
    Mark A; Christenson B; Granström M; Strandell A; Wickbom B; Böttiger M
    Eur J Clin Microbiol Infect Dis; 1989 Mar; 8(3):214-9. PubMed ID: 2496989
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Kinetics of vaccination antibodies against tetanus toxoid, diphtheria toxoid, measles virus, poliomyelitis virus and pneumococcus after allogenic and autologous bone marrow transplantation and booster vaccination. 2: Kinetics of vaccination antibodies against diphtheria toxoid after allogenic and autologous bone marrow transplantation].
    Prager J; Thilo W; Hermann J; Fuchs D; Zintl F
    Kinderarztl Prax; 1992 Oct; 60(7):195-8. PubMed ID: 1434337
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Diphtheria immunization in adolescents and adults with reduced doses of adsorbed diphtheria toxoid.
    Feery BJ; Benenson AS; Forsyth JR; Menser MA; Minty DW
    Med J Aust; 1981 Feb; 1(3):128-30. PubMed ID: 7219283
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Efficacy of diphtheria and tetanus vaccination in Gaza, Palestine.
    Al Aswad IH; Shubair ME
    East Mediterr Health J; 2009; 15(2):285-94. PubMed ID: 19554974
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Safety and immunogenicity of an indigenously developed tetanus toxoid, diphtheria toxoid, and acellular pertussis vaccine (Tdap) in adults, adolescents, and children in India.
    Sharma HJ; Parekh S; Pujari P; Shewale S; Desai S; Kawade A; Ravi M; Oswal J; James S; Mahantashetti N; Munshi R; Ghosh A; Rao V; Balsubramaniam S; Varughese P; Somshekhar A; Ginsburg AS; Rao H; Gautam M; Gairola S; Shaligram U
    Expert Rev Vaccines; 2023; 22(1):278-287. PubMed ID: 36883291
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Characteristics of immune response to diphtheria anatoxin in children with different immune status during the second age-scheduled revaccination].
    Kosenkova ; Fedorov GN; Vinogradova TV; Kovgunova II; Stefani DV
    Zh Mikrobiol Epidemiol Immunobiol; 2000; (5):45-8. PubMed ID: 11220964
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The immunizing efficiency of diphtheria toxoid when combined with various antigens.
    GREENBERG L; FLEMING DS
    Can J Public Health; 1948 Feb; 39(2):76. PubMed ID: 18933284
    [No Abstract]   [Full Text] [Related]  

  • 58. [ON COMBINED IMMUNIZATION BY PERTUSSIS-DIPHTHERIA-TETANUS AND SMALLPOX VACCINES].
    USMANOVA SA
    Zh Mikrobiol Epidemiol Immunobiol; 1963 Sep; 40():30-6. PubMed ID: 14119962
    [No Abstract]   [Full Text] [Related]  

  • 59. [Booster vaccination with a diphtheria-tetanus vaccine for dermo-jet with low diphtheria toxoid content].
    Wegmann A; Heiz R; Baumann T
    Schweiz Med Wochenschr; 1976 Jan; 106(4):112-4. PubMed ID: 1251161
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Antidiphtheria immunization, with special reference to diphtheria toxoid].
    SEPULVEDA D
    Rev Chil Pediatr; 1951 Jul; 22(7):297-304. PubMed ID: 14883496
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.